bioRxiv · 10.1101/2025.02.28.640920
Predicting Biological Age Using an Accumulated Neurotoxicity Biomarker for Amyloid Beta Oligomers
Abstract
This study proposes using accumulated neurotoxicity, defined as the time integral of A{beta} oligomer concentration, as a biomarker for neuronal aging. A relationship between biological age and accumulated neurotoxicity is proposed. Numerical analysis guided the development of a new analytical solution linking the biological and calendar ages of neurons. The effects of A{beta} monomer and oligomer half-lives--key indicators of proteolytic efficiency--on biological age are examined. Both constant and age-dependent (exponentially increasing) half-life scenarios are considered. The findings indicate that increasing the half-life of A{beta} monomers and oligomers with age accelerates biological aging. Reducing A{beta} monomer production is shown to slow biological aging, with a linear relationship established between these two quantities. Additionally, biological age is found to depend linearly on the half-deposition time of A{beta} oligomers into senile plaques. The model demonstrates that biological age is irreversible, providing a theoretical explanation for why plaque-clearing therapies cannot reverse established cognitive impairment. The model also demonstrates that biological age is path-dependent rather than state-dependent.
Source connections
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Kuznetsov, A. V.. 2025-03-06. Predicting Biological Age Using an Accumulated Neurotoxicity Biomarker for Amyloid Beta Oligomers. https://doi.org/10.1101/2025.02.28.640920
Cite the original work for its findings. Save a collection to share your selection of sources.